Reaction

Breast Cyst reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,758 reports · 17 co-occurring drugs

As of the last recalculation, Breast Cyst appears in 1,758 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE (PRR 24.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Conjugated Estrogens And Medroxyprogesterone Acetate4724.224.2
Estrogens, Conjugated8317.317.3
Conjugated Estrogens8117.217.2
Etonogestrel And Ethinyl Estradiol2513.513.5
Medroxyprogesterone Acetate4711.411.5
Octreotide Acetate2710.610.6
Estradiol669.49.4
Levonorgestrel1338.48.4
Progesterone157.87.8
Estradiol Gel 0.1%287.47.4
Estradiol Transdermal287.47.4
Valsartan And Hydrochlorothiazide87.07.0
Ocrelizumab295.65.6
Naltrexone Hydrochloride And Bupropion Hydrochloride34.24.2
Lurasidone Hydrochloride74.04.0
Drospirenone And Ethinyl Estradiol133.53.5
Etonogestrel92.22.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.